Sold as Ceclor, Ceclor Cd. Every FDA application for this active ingredient: 3 branded and 30 generic.
As of Nov 13, 2026, FDA lists 33 applications for Cefaclor (sold as Ceclor, Ceclor Cd), first approved Apr 4, 1979, with 0 new uses approved and 0 published complete response letters.
| Product | Part | Spending, 2024 | Change | Beneficiaries |
|---|---|---|---|---|
| Cefaclor | Part D | $532K | -11% | 5,414 |
| Cefaclor ER | Part D | $34K | -7% | 107 |
| Approved | Application | Sponsor | Supplements | Marketing |
|---|---|---|---|---|
| Apr 4, 1979 | CeclorNDA 50521 · New molecular entity | Lilly | 16 | Discontinued |
| Apr 4, 1979 | CeclorNDA 50522 · New active ingredient | Lilly | 19 | Discontinued |
| Apr 23, 1979 | CefaclorANDA 62206 | Facta Farma | 22 | Discontinued |
| Jul 28, 1979 | CefaclorANDA 62205 | Ceph Intl | 20 | Discontinued |
| Apr 27, 1995 | CefaclorANDA 64061 | Ivax Sub Teva Pharms | 3 | Discontinued |
| Apr 27, 1995 | CefaclorANDA 64107 | Dava Pharms Inc | 1 | Discontinued |
| Apr 28, 1995 | CefaclorANDA 64070 | Ivax Sub Teva Pharms | 2 | Discontinued |
| Apr 28, 1995 | CefaclorANDA 64085 | Ivax Sub Teva Pharms | 2 | Discontinued |
| Apr 28, 1995 | CefaclorANDA 64086 | Ivax Sub Teva Pharms | 2 | Discontinued |
| Apr 28, 1995 | CefaclorANDA 64087 | Ivax Sub Teva Pharms | 2 | Discontinued |
| Apr 28, 1995 | CefaclorANDA 64110 | Dava Pharms Inc | 1 | Discontinued |
| Apr 28, 1995 | CefaclorANDA 64114 | Dava Pharms Inc | 1 | Discontinued |
| Apr 28, 1995 | CefaclorANDA 64115 | Dava Pharms Inc | 1 | Discontinued |
| Apr 28, 1995 | CefaclorANDA 64116 | Dava Pharms Inc | 1 | Discontinued |
| May 23, 1996 | CefaclorANDA 64148 | Chartwell Rx | 7 | Discontinued |
| Jun 24, 1996 | CefaclorANDA 64145 | Teva | 4 | Discontinued |
| Jun 28, 1996 | Ceclor CdNDA 50673 · New dosage form | Lilly | 7 | Discontinued |
| Sep 16, 1996 | CefaclorANDA 64081 | Teva | 5 | Discontinued |
| Aug 28, 1997 | CefaclorANDA 64156 | Ranbaxy | 5 | Discontinued |
| Oct 2, 1997 | CefaclorANDA 64155 | Ranbaxy | 4 | Discontinued |
| Oct 2, 1997 | CefaclorANDA 64164 | Ranbaxy | 4 | Discontinued |
| Oct 2, 1997 | CefaclorANDA 64165 | Ranbaxy | 4 | Discontinued |
| Oct 2, 1997 | CefaclorANDA 64166 | Ranbaxy | 4 | Discontinued |
| Feb 18, 1998 | CefaclorANDA 64204 | Watson Labs Inc | 4 | Discontinued |
| Feb 18, 1998 | CefaclorANDA 64205 | Watson Labs Inc | 4 | Discontinued |
| Feb 18, 1998 | CefaclorANDA 64206 | Watson Labs Inc | 4 | Discontinued |
| Feb 18, 1998 | CefaclorANDA 64207 | Watson Labs Inc | 4 | Discontinued |
| Jan 5, 2001 | CefaclorANDA 65057 | World Gen | 2 | Discontinued |
| Sep 4, 2002 | CefaclorANDA 65058 | Teva | 4 | Marketed |
| Dec 22, 2003 | RaniclorANDA 65092 | Ranbaxy Labs Ltd | 0 | Discontinued |
| Jan 22, 2004 | CefaclorANDA 65146 | Yung Shin Pharm | 3 | Marketed |
| Apr 3, 2007 | CefaclorANDA 65350 | Hikma | 1 | Discontinued |
| Feb 17, 2012 | CefaclorANDA 65412 | Yung Shin Pharm | 2 | Marketed |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number. Drugs@FDA
Lilly
Teva